Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

2(40.0%)

N/A

2(40.0%)

Phase 2

1(20.0%)

5Total

Phase 4(2)

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05963685Unknown

Impact of a Standardized Alarming System on Treatment Times and Workflow in Stroke Patients With Interhospital Transfer for Thrombectomy

Role: lead

NCT04270513Unknown

Flying Intervention Team for Endovascular Treatment of Acute Ischemic Stroke in Rural Areas

Role: lead

NCT02320383Phase 2Unknown

CLLR3: Bendamustine + GA101 (BG) in Relapsed or Refractory CLL Followed by GA101 Maintenance for Responding Patients

Role: lead

NCT02938221Not ApplicableCompleted

Telemedical Examination of a Three-Component Oculomotor Testing Battery

Role: lead

NCT01035528Phase 4Unknown

Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)

Role: lead

NCT01004757Not ApplicableUnknown

Effects of Low Versus High Carbohydrate Diet During Rehabilitation on Cardiovascular Function and Metabolism in Type 2 Diabetes

Role: lead

NCT00747409Phase 4Unknown

Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes

Role: lead

All 7 trials loaded